|
05/20/2013
Two Bio-Rad promotional videos received Telly Awards at the annual awards ceremony in April. Selected from among 12,000 entries, the winning submissions were promotions for the Bio-Rad Science Ambassador Program and the new NGC™ medium-pressure chromatography system.
More »
|
05/09/2013
Bio-Rad’s PrimePCR assays for quantitative real-time PCR (qPCR), the industry’s only real-time PCR primers experimentally validated to ensure performance, have been expanded to include assays and panels for the mouse genome.
More »
|
|
05/06/2013
As anticipated, scientists and teachers in Canada are sharing their passion for science and getting involved in the Bio-Rad Science Ambassador Program. Started in the US, the program matches life science teachers with scientist volunteers and provides free supplies for a fun and educational classroom activity.
More »
|
05/02/2013
A new study demonstrates that Droplet Digital PCR (ddPCR™) technology is suitable for routine analysis of genetically modified organisms (GMOs) in food, feed, and seeds. The ddPCR assay is more accurate and reliable than real-time quantitative PCR (qPCR) for quantifying GMOs, especially at low levels.
More »
|
|
04/16/2013
Bio-Rad’s new ddPCR library quantification kit for Illumina TruSeq sample preparation kits enables QX100™ Droplet Digital™ PCR system users to precisely and directly measure amplifiable library concentrations for next-generation sequencing.
More »
|
04/09/2013
Droplet Digital PCR (ddPCR™) technology dramatically enhances current telomerase activity assays, with important implications for the early detection of cancer and the rapid evaluation of cancer therapeutics.
More »
|
|
03/12/2013
The QX100™ Droplet Digital™ PCR system was cited as the future market leader in digital PCR systems for its precision, simple workflow, and affordability. More than half of the researchers surveyed plan to buy a QX100 system in the next year
More »
|
03/09/2013
Bio-Plex Pro RBM human, rat, and canine kidney toxicity panels, developed in partnership with Myriad RBM, Inc., enable earlier quantitation of FDA-approved markers of acute and chronic kidney injury in clinical and preclinical settings with unprecedented sensitivity.
More »
|
|
02/20/2013
Bio-Rad has completed the acquisition of AbD Serotec, a leading antibody manufacturer offering over 15,000 antibodies, kits, and accessories. This acquisition will accelerate future antibody development and enhance product offerings in diagnostics and life science research.
More »
|
02/07/2013
As part of the recently-launched Bio-Rad Science Ambassador Program, students in the sixth and seventh grade at Jefferson Middle School conducted the Genes in a Bottle™ experiment under the guidance of Science Ambassador, Dr. Lisa Eccles.
More »
|
|
